Dear Madam, Dear Sir, Dear patient, Dear colleague,
COVID19 INFORMATION :
During the current epidemic, any immunocompromised patient, whether undergoing, or about to undergo, stem cell therapy (Autograft or Mesenchymal Stem Cells) or not, must contact the hospital secretariat where (s)he is usually followed before going there. For:
CHU de Lille : consultations : 03 20 44 42 85/ hospitalisations : 03 20 44 44 33.
Telemedicine consultations have been deployed by each of your referring physicians. Transplant patients who are currently undergoing stem cell therapy or who are being followed after having undergone transplant therapy can call the ALLO MATHEC phone number : 06 24 81 03 91, and we will take care of you. Outside of these hours, you can send an email to: firstname.lastname@example.org Please also carefully read the SFGM-TC , the Fai2r and the inserm recommendations pertaining to Covid19.
It is important to adhere to the rules of confinement to ensure everyone's safety. You can read an article on the subject : here The Sanofi-aventis France laboratory has committed to supplying Plaquenil to all patients taking the drug within the specifications of the Marketing Authorization. If the pharmacist no longer has Plaquenil in stock, an emergency restocking system has been put in place. The pharmacist should contact the medical information service of Sanofi-aventis France which will initiate the restocking procedure. Patients may have to wait a few days before they can resume treatment if they have run out of medication.
To increase knowledge, improve clinical practice and patient care, and advance translational research in individuals with autoimmune diseases treated with bone marrow transplant or other cell therapies in France.